VBI Vaccines Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
48,541.70
37,767.70
12,476.00
32,282.00
67,694.00
59,270
Total Accounts Receivable
46.00
39.40
93.00
10.00
143.00
56
Inventories
-
-
1,316.00
830.00
788.00
911
Other Current Assets
50.70
47.50
637.00
1,236.00
1,801.00
1,494
Total Current Assets
48,638.30
37,854.60
14,522.00
34,358.00
70,426.00
61,731
Net Property, Plant & Equipment
124,746.70
96.30
1,750.00
1,850.00
2,245.00
8,525
Total Investments and Advances
32.10
29.60
-
-
-
-
Long-Term Note Receivable
2,459.20
2,764.80
-
-
-
-
Intangible Assets
-
116,660.20
386.00
67,892.00
72,310.00
66,514
Other Assets
-
-
387.00
654.00
675.00
835
Total Assets
175,876.30
157,405.40
17,045.00
104,754.00
145,656.00
137,605
ST Debt & Current Portion LT Debt
-
-
-
-
1,600.00
Accounts Payable
160.10
175.20
408.00
2,018.00
1,810.00
Other Current Liabilities
80.30
74.00
2,521.00
5,596.00
9,826.00
Total Current Liabilities
240.40
249.20
2,929.00
7,614.00
13,236.00
Long-Term Debt
-
-
-
8,612.00
11,538.00
Provision for Risks & Charges
-
-
-
356.00
426.00
Deferred Taxes
-
-
-
428.00
-
Other Liabilities
-
-
1,922.00
4,013.00
669.00
Total Liabilities
240.40
249.20
4,851.00
21,023.00
25,869.00
Common Equity (Total)
175,635.90
157,156.20
12,194.00
83,731.00
119,787.00
Total Shareholders' Equity
175,635.90
157,156.20
12,194.00
83,731.00
119,787.00
Total Equity
175,635.90
157,156.20
12,194.00
83,731.00
119,787.00
Liabilities & Shareholders' Equity
175,876.30
157,405.40
17,045.00
104,754.00
145,656.00

About VBI Vaccines

View Profile
Address
222 3rd Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.vbivaccines.com
Updated 07/08/2019
VBI Vaccines, Inc. is a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. Its pipeline includes Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.